WHO Expert Panel On Innovation In Funding For R&D Faces Criticism

“A WHO expert panel set up to find new ways to fund health research for neglected diseases has defeated the purpose of the initiative by selecting less-ambitious rather than mold-breaking ideas, civil society groups have said,” SciDev.Net reports. “At a meeting in Geneva, Switzerland, earlier this month (December 3-5), the panel shortlisted several ‘demonstration projects’ intended as examples of innovation in funding research and development (R&D) for neglected diseases and other health issues that have fallen through the cracks of the current global R&D system, particularly in developing countries,” the news service notes. However, “there is nothing new in the seven research proposals, plus one side proposal, that were chosen, according to Judit Rius Sanjuan, who attended the meeting and who manages the U.S. Access Campaign for Médecins Sans Frontières (MSF), which promotes global access to medicines and diagnostic tests,” the news service writes and examines “[c]urrent efforts to find new funding models for health R&D” and discusses “criticism of the panel’s selection” (Dobrovolny, 12/18).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.